Written & researched by Racheal Tan, Product Development Writer · Reviewed by Creaton Poh · Published by OEM2YOU · Last reviewed August 2026
Topical relief looks like an easy category to enter. It is a short ingredient list, a familiar format, and a product customers already understand. Then the first quotation arrives, the deposit goes out, and three months later the brand discovers its product name cannot be used, or that the registration it assumed would take a fortnight takes five months.
Almost all of that is avoidable at the enquiry stage. These are the seven questions worth asking before any money changes hands — and, just as importantly, what a good answer sounds like.
Quick answer
Before paying a deposit on a pain relief cream or cooling gel, establish which registration route the product falls under, who will hold the notification or registration, what the label may legally claim, whether the product name is permitted, what the real MOQ and lead time are, what stability testing is included, and what happens if the regulator rejects the submission. A manufacturer who cannot answer the first three clearly is answering the rest of them for a product that may not exist.
1. Which registration route is my product on — and who decided?
In Malaysia a topical relief product can be a cosmetic notified with the National Pharmaceutical Regulatory Agency (NPRA), a medicine requiring MAL registration, or a medical device registered with the Medical Device Authority (MDA). The route follows the product’s primary mode of action and its claims.
What a good answer sounds like: the manufacturer names the route, explains what drives it — sensory cooling versus a pharmacological active — and says what would change it.
What should worry you: “Don’t worry, we handle registration.” That is a service description, not an answer. The route determines your launch date, and you should hear it before you hear a price.
2. Who holds the notification — me or the factory?
This is the question buyers ask least and regret most. Under Malaysia’s cosmetic framework the Cosmetic Notification Holder carries the regulatory responsibility: ensuring the product meets requirements, maintaining the Product Information File, and executing a recall if one is directed.
Whoever holds the notification effectively controls the product’s route to market. If the factory holds it, moving your brand to another manufacturer later is not a simple transfer.
What a good answer sounds like: a clear statement of who is named as holder, why, and what happens to the notification if the relationship ends. There are legitimate reasons for either arrangement — there is no legitimate reason for it to be vague.
3. What exactly can my label say?
NPRA publishes the acceptable and unacceptable claims for cosmetic products by category. For products assisting body massage, reference to relieving pain or ache of the body, muscle or joint is unacceptable, as is “improve blood circulation”. Calming, relaxing, refreshing, uplifting and moisturizing are acceptable.
If your brand proposition is built on a claim you cannot make, you do not have a labelling problem. You have a product-route problem, and it is better discovered now.
| Ask this | Because |
|---|---|
| Can you show me the claim list for my product category? | It is a published NPRA document. A manufacturer working in this category should be able to produce it. |
| Which of my draft claims would you remove? | Tests whether they have actually read your copy. |
| Does this apply to my ads and videos too? | It does. Advertising is assessed under its own guideline. |
4. Is my product name allowed?
Separately from claims, NPRA restricts product names for notified cosmetics — including names referring to diseases or medical conditions, and to body parts outside the cosmetic scope such as muscle, joint and nerve, along with their Malay equivalents.
This catches brands late and expensively, because the name is usually the first thing decided and the last thing checked. Ask for the name to be reviewed before artwork is commissioned, not before it is printed.
5. What is the real MOQ — and the real lead time?
Ask for both numbers to be broken into parts, because a single figure hides the risk:
- MOQ for the bulk formula versus MOQ for the packaging component. Packaging is very often the real constraint — a printed tube or a custom cap can carry a far higher minimum than the cream inside it.
- Lead time for formulation and sampling, for stability testing, for registration, and for production. A quoted “four weeks” that excludes registration is not wrong, but it is not your launch date either.
A ready formula on the cosmetic route can move quickly because the notification note issues once the submission and payment go through. A custom formula with an analgesic active cannot, because NPRA’s evaluation for a traditional product runs to 116 working days for a single active ingredient and 136 for two or more.
6. What testing is included, and what is extra?
For a cooling gel specifically, two tests matter more than the generic list:
- Stability in your actual packaging. Cooling agents are volatile. A gel that cools well in a laboratory jar and weakly in your chosen tube after six months is a packaging failure that testing in the real pack would have caught.
- Temperature cycling. Menthol can recrystallise out of a gel after a cold transport leg, showing up as gritty particles. This is visible, and customers return it.
Also confirm who pays for retesting if the formula is adjusted after your feedback. That is a common source of unbudgeted cost.
7. What happens if the submission is rejected?
Ask it plainly, and ask for the answer in the quotation rather than in conversation:
- Who bears the cost of new artwork if the product name is not accepted?
- Who reworks the formula if an ingredient level needs changing, and at whose cost?
- What is the timeline impact, and does your deposit hold the production slot?
A manufacturer who has been through this before will answer without hesitation, because they have already had the conversation with someone else.
The three answers that should stop you
| If you hear this | What it usually means |
|---|---|
| “You can write pain relief, everyone does it” | They are describing what unregistered sellers do, and the regulatory exposure lands on the notification holder — which may be you. |
| “Registration takes about two weeks” — for a product with an analgesic active | They are quoting the cosmetic timeline for a product that is not a cosmetic. |
| “We’ll sort the label out at the end” | Artwork will be printed before anyone checks the name. This is the single most common avoidable cost in the category. |
Frequently asked questions
Do I need a MAL number for a cooling gel?
Not if it is genuinely a cosmetic — working by a cooling sensation, with no therapeutic claim on the name, label or advertising. It is then notified with NPRA. A product claiming pain relief, or containing an analgesic active such as methyl salicylate or capsaicin, requires MAL registration.
Can the factory register the product in my company’s name?
Arrangements vary and both models exist in the market. What matters is that it is stated explicitly before you pay, because the holder carries the regulatory responsibility and, practically, controls the product’s route to market.
Why is the packaging MOQ higher than the formula MOQ?
Printed components are usually produced in fixed print runs. It is common for the packaging supplier, not the formulation, to set your true minimum order.
Is a cooling patch the same category as a cooling gel?
No. A patch that works by physically drawing heat away is regulated as a medical device by the MDA, on a different timeline and cost base from a notified cosmetic gel.
How do I check a manufacturer’s claims about certification?
Ask for the certificate with its scope and expiry, and verify the scope covers the product type you are making. A certification that covers one product category does not automatically cover another. Note also that GMP and ISO 22716 logos may not be printed on a cosmetic label, even when the certification is genuine.
Sources & references
- NPRA — Guidelines for Control of Cosmetic Products in Malaysia — notification framework and the responsibilities of the Cosmetic Notification Holder.
- NPRA — Annex I, Part 8: Guideline for Cosmetic Claims — acceptable and unacceptable claims by product category.
- NPRA — Annex I, Part 2: Non-Permissible Product Name — restricted product names.
- NPRA — MDDCI classification table — how cooling pads and medicinal patches are classified.
Update history
August 2026 — First published.